SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Winter in the Great White North
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claude Cormier who wrote (8076)2/18/2017 5:38:09 PM
From: 3bar2 Recommendations

Recommended By
Frankly Speaking
ogi

  Read Replies (1) of 8273
 
Here is a stock with a story that doesn't happen too often but when it does catches ones attention .

A company trying a novel approach to Cancer had 100 % kill of human cancer in a mouse . It also had 0 side effects ie; adjacent cells showed no harmful effects . + After trying to inject the same cancer into the mice 3 times over 3 months and it would not take . The researchers concluded it was an immune response .

This testing was done by Princess Margaret Hospital in Toronto . The #2 center for cancer research globally .

They have just started human trials . Subject 59473
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News